Merck & Co., Inc. (NYSE:MRK)

CAPS Rating: 3 out of 5

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health.


Player Avatar nitraMcoD (< 20) Submitted: 8/25/2006 4:56:57 AM : Underperform Start Price: $29.04 MRK Score: -41.01

There are fundamental shifts occurring in the industry that will eat away at the efficiencies MRK currently enjoys. While their response to these shifts will be correct, their size will slow down their reaction time, causing loss of confidence in the investment community.

Featured Broker Partners